Needham analyst Mayank Tandon raised the firm’s price target on Genpact (G) to $53 from $50 and keeps a Buy rating on the shares. The company posted solid Q2 results, beating estimates on all fronts, given broad-based demand improvement through the quarter, especially for Genpact’s AI-based solutions, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on G: